CURE.DE vs. WELP.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and WELP.DE (HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while WELP.DE tracks the MSCI World/Energy NR USD. Both are passively managed. Over the past 3 years, CURE.DE returned -0.09%/yr vs 12.49%/yr for WELP.DE. At a 0.14 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.59%/yr for WELP.DE.
Performance
CURE.DE vs. WELP.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a 0.01% return, which is significantly lower than WELP.DE's 25.35% return.
CURE.DE
- 1D
- 0.00%
- 1M
- 11.67%
- YTD
- 0.01%
- 6M
- -0.48%
- 1Y
- 14.68%
- 3Y*
- -0.09%
- 5Y*
- —
- 10Y*
- —
WELP.DE
- 1D
- 0.00%
- 1M
- -7.19%
- YTD
- 25.35%
- 6M
- 26.72%
- 1Y
- 34.31%
- 3Y*
- 12.49%
- 5Y*
- —
- 10Y*
- —
CURE.DE vs. WELP.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.01% | 5.09% | 0.30% | -6.42% | -4.11% |
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 25.35% | -1.54% | 7.90% | 0.25% | 5.34% |
Correlation
The correlation between CURE.DE and WELP.DE is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2022 | 0.14 |
The correlation between CURE.DE and WELP.DE shifts across timeframes, from -0.06 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. WELP.DE — Risk / Return Rank
CURE.DE
WELP.DE
CURE.DE vs. WELP.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE.DE | WELP.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.03 | ||
| Sortino ratioReturn per unit of downside risk | -1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.31 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.77 | 2.80 | -2.02 |
| Martin ratioReturn relative to average drawdown | 1.66 | 8.57 | -6.91 |
Loading charts...
Drawdowns
CURE.DE vs. WELP.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than WELP.DE's maximum drawdown of -23.55%. Use the drawdown chart below to compare losses from any high point for CURE.DE and WELP.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | WELP.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -23.55% | -11.25% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -12.22% | -6.85% |
Max Drawdown (3Y)Largest decline over 3 years | -29.29% | -23.55% | -5.74% |
Current DrawdownCurrent decline from peak | -11.12% | -11.07% | -0.05% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -7.79% | -7.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.87% | 3.99% | +4.88% |
Volatility
CURE.DE vs. WELP.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a higher volatility of 7.10% compared to HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) at 6.59%. This indicates that CURE.DE's price experiences larger fluctuations and is considered to be riskier than WELP.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | WELP.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.10% | 6.59% | +0.51% |
Volatility (6M)Calculated over the trailing 6-month period | 15.59% | 16.90% | -1.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.41% | 19.54% | +0.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.75% | 20.07% | +0.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.75% | 20.07% | +0.68% |
CURE.DE vs. WELP.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is lower than WELP.DE's 0.59% expense ratio.
Dividends
CURE.DE vs. WELP.DE - Dividend Comparison
CURE.DE has not paid dividends to shareholders, while WELP.DE's dividend yield for the trailing twelve months is around 3.05%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.00% | 0.00% | 0.00% | 0.00% |
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 3.05% | 3.78% | 3.64% | 0.79% |
Frequently Asked Questions
CURE.DE and WELP.DE have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CURE.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CURE.DE is cheaper with a 0.35% expense ratio, compared with 0.59% for WELP.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while WELP.DE tracks MSCI World/Energy NR USD. They also come from different issuers: VanEck and Amundi. Their fees differ too: 0.35% for CURE.DE and 0.59% for WELP.DE.
Find the right allocation for CURE.DE and WELP.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer